Triheptanoin treatment in ataxia-telangiectasia: the significance of innovative clinical trials targeting mitochondrial dysfunction
Saved in:
| Main Author: | Osamu Onodera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | EBioMedicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396425003263 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosisResearch in context
by: Matthew Lynch, et al.
Published: (2025-08-01) -
Ataxia telangiectasia
by: Letícia Sauma, et al.
Published: (2015-07-01) -
ATAXIA-TELANGIECTASIA
by: Y Renda
Published: (1964-04-01) -
Ataxia-telangiectasia
by: Nelson Pires Ferreira
Published: (1966-09-01) -
Síndrome de Ataxia-Telangiectasia Ataxia-telangiectasia: a case report
by: Amauri Batista da Silva, et al.
Published: (1971-06-01)